Hims & Hers Health, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| HIMS | MEGA.BK | PBH | THEMISMED.BO | 034940.KQ | 600267.SS | |
|---|---|---|---|---|---|---|
| Market cap | 6.22B | 30.95B | 2.52B | 9.36B | 9.98B | 16.32B |
| P/E (TTM) | — | 14.2 | 14.9 | 23.5 | — | 13.2 |
| Forward P/E | 36.2 | 12.4 | 10.4 | — | — | 37.4 |
| Price/book | 19.2 | 3.0 | 1.3 | 2.4 | — | 1.7 |
| Dividend yield | — | 4.86% | — | 0.50% | — | 1.57% |
| 1-year change | −41.23% | +20.69% | −17.20% | −16.36% | −69.57% | +22.06% |
| Today | +3.74% | +1.43% | +7.55% | +1.22% | 0.00% | +3.29% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All HIMS news ›Hims & Hers Health, RadNet, and Henry Schein shares are soaring, what you need to know
A number of stocks jumped in the afternoon session after election results confirmed that Democrats reclaimed majorities in the House and Senate, easing regulatory uncertainty around drug pricing policy. Zooming in on RadNet (RDNT) RadNet’s…
HIMS Deadline: HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit
NEW YORK, Nov. 2, 2026 /PRNewswire/ -- 2, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both…
More from 2 other outlets
- TMX Newsfile HIMS INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline
- @PRNewswire HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - November 2, 2026 Deadline
Hims & Hers Health, Inc. (NYSE:HIMS) SHAREHOLDER ALERT: Investors With Losses May Seek to Lead the Class Action in Hims & Hers Health, Inc. Securities Lawsuit - Contact Portnoy Law Firm
Please visit our website for more information on how to participate in this class action. WHY PORTNOY LAW FIRM Lead Plaintiff Deadline: Investors who suffered losses on Hims & Hers Health, Inc. stock during the Class Period have until…
California’s New Healthcare Transaction Regulations Clarify Filing Requirements for PE Funds, Hedge Funds and MSOs
McGuireWoods - New OHCA regulations effective Nov. 2, 2026, implement Assembly Bill 1415 and require private equity groups, hedge funds, MSOs and newly created acquisition entities to f
Beauty Health $18 Million Securities Class Action Settlement
Investors who bought or sold Beauty Health securities between May 10, 2022, and Nov. 13, 2023, may be eligible to claim cash from a class action settlement. Investors who purchased or otherwise acquired The Beauty Health Co. common stock…
HIMS Deadline in 3 Days: Hims & Hers Health, Inc. (HIMS) Class Action Lawsuit Seeks Recovery for Investors; November 2, 2026 Deadline- Contact Kessler Topaz Meltzer & Check, LLP
Oct 30, 2026, 08:40 ET Did you buy HIMS securities between August 4, 2025 and July 29, 2026? Affected HIMS Investor Summary CONTACT KTMC TO DISCUSS YOUR LEGAL RIGHTS: If you purchased or acquired HIMS securities and have lost money on your…
Teladoc Soars 26% as Revenue and Profit Beat Estimates; Hims & Hers Health and American Well Tick Up
Teladoc posted falling revenue yet still managed to beat Wall Street on both sales and profit, sending shares surging. The real question is whether a surprising shift inside its BetterHelp unit can turn a struggling business into a growth…
What Should Hims & Hers Health, Inc. Investors Know After 14.73% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline
Oct 30, 2026, 13:10 ET Lawsuit alleges Hims & Hers Health, Inc. made misleading statements to investors from August 4, 2025 to July 29, 2026; lead plaintiff motions are due November 2, 2026 If you lost money on Hims & Hers Health, Inc.…
HIMS Stock Gains As Company Enters German Men’s Weight Market As Investors Watch US Peptide Compounding Policy
Shares of Hims & Hers Health (HIMS) rose 6% on Tuesday, as the company launched in Germany with a new men’s weight-management offering, adding another layer of international expansion. Hims is introducing online weight-management care for…
Financial Comparison: Hims & Hers Health (NYSE:HIMS) & Exagen (NASDAQ:XGN)
Posted by Defense World Staff on Oct 28th, 2026 Hims & Hers Health (NYSE:HIMS – Get Free Report) and Exagen (NASDAQ:XGN – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- globenewswire.com29
- prnewswire.com22
- newsfilecorp.com15
- invezz.com6
- natlawreview.com5
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.